Lomitapide and Mipomersen
Authors:
- 4 March 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 129 (9) , 1022-1032
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial HypercholesterolemiaCirculation, 2012
- Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteinsJournal of Lipid Research, 2012
- Multiple functions of microsomal triglyceride transfer proteinNutrition & Metabolism, 2012
- Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemiaDiabetologia, 2011
- Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient miceJournal of Lipid Research, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Dissociation Between Intrahepatic Triglyceride Content and Insulin Resistance in Familial HypobetalipoproteinemiaGastroenterology, 2010
- The ever-expanding role of degradation in the regulation of apolipoprotein B metabolismJournal of Lipid Research, 2009
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999